The Drug Industry's Alliance Archipelago
- Topics:
- Pharmeceuticals
- Tags:
- Accenture Ltd.,
- Alliance,
- Biotechnology,
- Biotechnology Company,
- Industry,
- Pharmaceutical Company
- Source:
- Accenture
FREE Registration is required
Overview: Big pharmaceuticals have the money to fund the development and marketing of new drugs, but their R&D hit rate has not been sufficient to replace products coming off patent. Small biotechnology companies are awash in new technologies, but lack the cash to bring products through the expensive regulatory approval processes. Large biotechnology companies have products, but lack the sales muscle to market these broadly. The report explores why alliances have been challenging and how biotechnology and pharmaceutical companies can make them more effective.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: PDF | Size: 235KB | Date: Dec 2003 | Pages: 14



